Array-based genomic resequencing of human leukemia (original) (raw)

• Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG et al. (2008). Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456: 53–59.
  Article CAS Google Scholar
• Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. (2002). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from cancer and leukemia Group B (CALGB 8461). Blood 100: 4325–4336.
  Article CAS Google Scholar
• Choi YL, Kaneda R, Wada T, Fujiwara S, Soda M, Watanabe H et al. (2007). Identification of a constitutively active mutant of JAK3 by retroviral expression screening. Leuk Res 31: 203–209.
  Article CAS Google Scholar
• Ehrlich M . (2003). The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol 109: 17–28.
  Article CAS Google Scholar
• El-Osta A . (2004). The rise and fall of genomic methylation in cancer. Leukemia 18: 233–237.
  Article CAS Google Scholar
• Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ . (1983). Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80: 2931–2935.
  Article CAS Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G et al. (2007). Patterns of somatic mutation in human cancer genomes. Nature 446: 153–158.
  Article CAS Google Scholar
• Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. (1998). The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92: 2322–2333.
  CAS Google Scholar
• Imanishi D, Miyazaki Y, Yamasaki R, Sawayama Y, Taguchi J, Tsushima H et al. (2007). Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants. Blood 110: 2231–2234.
  Article CAS Google Scholar
• Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H et al. (2004). Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 21: 843–851.
  Article CAS Google Scholar
• Jia D, Jurkowska RZ, Zhang X, Jeltsch A, Cheng X . (2007). Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 449: 248–251.
  Article CAS Google Scholar
• Kiyoi H, Yamaji S, Kojima S, Naoe T . (2007). JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults. Leukemia 21: 574–576.
  Article CAS Google Scholar
• Koinuma K, Kaneda R, Toyota M, Yamashita Y, Takada S, Choi YL et al. (2005). Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter. Carcinogenesis 26: 2078–2085.
  Article CAS Google Scholar
• Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. (2005). A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352: 1779–1790.
  Article CAS Google Scholar
• Kubonishi I, Miyoshi I . (1983). Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. Int J Cell Cloning 1: 105–117.
  Article CAS Google Scholar
• Kwong YL, Wong KF, Chan V, Chan CH . (1996). Persistence of AML1 rearrangement in peripheral blood cells in t(8;21). Cancer Genet Cytogenet 88: 151–154.
  Article CAS Google Scholar
• Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K et al. (2008). DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456: 66–72.
  Article CAS Google Scholar
• Miyamoto T, Nagafuji K, Akashi K, Harada M, Kyo T, Akashi T et al. (1996). Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood 87: 4789–4796.
  CAS PubMed Google Scholar
• Miyamoto T, Weissman IL, Akashi K . (2000). AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 97: 7521–7526.
  Article CAS Google Scholar
• Nimer SD, Moore MA . (2004). Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells. Oncogene 23: 4249–4254.
  Article CAS Google Scholar
• Okano M, Bell DW, Haber DA, Li E . (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247–257.
  Article CAS Google Scholar
• Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL et al. (1996). Applications of retrovirus-mediated expression cloning. Exp Hematol 24: 324–329.
  CAS PubMed Google Scholar
• Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR et al. (2001). Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294: 1719–1723.
  Article CAS Google Scholar
• Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M et al. (2006). MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3: e270.
  Article Google Scholar
• Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ et al. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270: 797–800.
  Article CAS Google Scholar
• Sato T, Toki T, Kanezaki R, Xu G, Terui K, Kanegane H et al. (2008). Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome. Br J Haematol 141: 681–688.
  Article CAS Google Scholar
• Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. (2008). Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1909–1918.
  Article CAS Google Scholar
• Schwonzen M, Diehl V, Dellanna M, Staib P . (2007). Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis. Leuk Res 31: 113–116.
  Article CAS Google Scholar
• Shimada A, Taki T, Tabuchi K, Tawa A, Horibe K, Tsuchida M et al. (2006). KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group. Blood 107: 1806–1809.
  Article CAS Google Scholar
• Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268–274.
  Article Google Scholar
• Suetake I, Miyazaki J, Murakami C, Takeshima H, Tajima S . (2003). Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. J Biochem 133: 737–744.
  Article CAS Google Scholar
• Tallman MS, Altman JK . (2008). Curative strategies in acute promyelocytic leukemia. Hematol Am Soc Hematol Educ Program 2008: 391–399.
  Article Google Scholar
• Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M et al. (2006). Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 10: 65–75.
  Article CAS Google Scholar
• Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A et al. (2008). The complete genome of an individual by massively parallel DNA sequencing. Nature 452: 872–876.
  Article CAS Google Scholar
• Wong S, Witte ON . (2001). Modeling Philadelphia chromosome positive leukemias. Oncogene 20: 5644–5659.
  Article CAS Google Scholar
• Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S et al. (2001). Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97: 2434–2439.
  Article CAS Google Scholar